Literature DB >> 12170764

Increased apoptosis in metastatic human colonic adenocarcinomas.

Paula M Termuhlen1, Bridget M Sweeney-Gotsch, Russell S Berman, Lee M Ellis, Corazon Bucana, Yu Shen, Karen R Cleary, David J McConkey.   

Abstract

Recent work suggests that apoptosis is disrupted during the progression of many solid tumors. Isogenic metastatic colon adenocarcinoma cells displayed significantly higher levels of staurosporine-induced apoptosis compared to their nonmetastatic counterparts in vitro. In addition, analysis of 15 matched primary tumors and liver metastases demonstrated that the levels of apoptosis were significantly higher in the metastases, and this increased cell death was associated with significantly lower levels of Bcl-2 protein expression. Our data demonstrate that the molecular events associated with acquisition of the metastatic phenotype sensitize colon cancer cells to some pro-apoptotic stimuli.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12170764     DOI: 10.4161/cbt.1.1.43

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  4 in total

1.  Identification of Key Carcinogenic Genes in Colon Adenocarcinoma.

Authors:  Yangbin Dai; Zhenjian Jiang; Yanru Qiu; Yiping Kang; Huangzhen Xu; Tianwen Xu
Journal:  Iran J Public Health       Date:  2022-02       Impact factor: 1.479

2.  Significance of apoptosis in metastasizing testis tumors.

Authors:  M Abend; M Port; H U Schmelz; K Kraft; C Sparwasser
Journal:  Urol Res       Date:  2003-10-25

3.  Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients.

Authors:  Changshun Yang; Yu Zhang; Xiaoqin Xu; Weihua Li
Journal:  Aging (Albany NY)       Date:  2019-12-18       Impact factor: 5.682

4.  CA1 contributes to microcalcification and tumourigenesis in breast cancer.

Authors:  Yabing Zheng; Bing Xu; Yan Zhao; He Gu; Chang Li; Yao Wang; Xiaotian Chang
Journal:  BMC Cancer       Date:  2015-10-12       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.